🆕UPDATED GROWTH PORTFOLIO 1/06/26:
1. $FOUR 24%
2. $AMD 18%
3. $MELI 12%
4. $BTC 10%
5. $HIMS 9%
6. $OSCR 8%
7. $AMZN 7%
8. $DLO 6%
9. $PYPL 5%
10. $PATH 2%
Not much has changed from the December update with exception of adding $PATH.
I'd like to get out of $PYPL at some point mostly to consolidate into my existing names as I don't usually have this many names in my portfolio.
$HIMS. Institutional Ownership is rising meanwhile short interest and retail ownership declining. 🤔
Volume is declining since November, sellers getting tired.
Analyst projecting $HIMS grows between 19% in 2026 down to closer to 10% after that through 2030. 😂😂
Sure $HIMS could keep dropping but one thing is for sure, this shit will be back to ATH in the future.
Growth will accelerate behind Labs Flywheel and expansion into new verticals. Some exciting verticals like peptides are exponential growth triggers. Another one is the micro needle at home lab testing.
Continuing to buy here and if it falls into the $20's will get as aggressive as possible on this.
I'll be the first to say $TSLA appears over-valued right now.
HOWEVER, Based on the new update FSD 14.2.2.2....probably not the best time to dump your shares.
I experienced for the first time today after using FSD for the last year and this is the one.
What's more crazy to me, I constantly have people coming up to me when I summon my car in shock about what they're seeing. Ridiculous people don't know about what $TSLA is cooking.
x.com/MrFundaTechnic…
🚨Took a starter pack of 1,000 shares in $PATH at $16.92 joining the fintwit wave.
Few Things I like:
1. operating leverage is accelerating with revenues growing ahead of expenses.
2. Topline sales appear to be accelerating compared with analyst estimates via AI tailwinds (MAESTRO) which just launched in April.
3. CEO/Founder Leader
4. approx. 1.5B cash/equivalents with no debt.
5. extremely high margin company.
6. as @jakebrowatzke points out if you listen to the last earnings call oddly majority of analysts covering the stock are having their minions cover the call in their place.
7. Agentic theme seems like a great one to invest in for 2026 given $META just bought Manus AI was does agentic for B2C. $PATH is B2B for enterprise/government.
8. Doubled the amount of clients developing agents last quarter, yet no revenue from MAESTRO contributing to current results.
9. MOST OF ALL. I like that the pricing model for MAESTRO isn't like their RPA business. It is based instead on value creation at the end user/customer. This could really create exponential growth for $PATH.
🤔If I use FY2027 estimates of $83 per share and assume even a lower P/E ratio of 35 compared with historical norms for $MELI
I get a $2,905 stock. Let's round up to $3K or around a 50% gain from here within the next couple years.
🆕UPDATED GROWTH PORTFOLIO 12/22/25:
1. $FOUR 28%
2. $AMD 17%
3. $MELI 12%
4. $BTC 10%
5. $HIMS 9%
6. $OSCR 7%
7. $AMZN 7%
8. $DLO 6%
9. $PYPL 5%
Over the last month I did add to $MELI, $AMZN, $HIMS, and $AMD.
Pretty happy riding this portfolio out long term. All of the names maybe outside $AMD are off highs.
Can literally go down the list and make a case for all these names to 2-3X in the next 2-3 years (Maybe excluding $AMZN).
@cutsclothing bought your expensive AO pant with a 15% off coupon. Now trying to exchange and I have to pay $15 more because you won’t honor my original coupon. After repeated emails customer service won’t budge. Last time I order from you all for not treating customers well.
$Hbar - 1) secure 2) fast 3) fixed transaction fees 4) hashpack - staking made easy 5) lowest energy consumption 6) top companies as council members.
#HBarbarian add more ⬇️